BIOMAT Database Logo BIOMAT Database Logo

Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin-treated Type 2 diabetes. 2009

K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
Severe hypoglycaemia in insulin-treated Type 2 diabetes.
March 2007, Diabetic medicine : a journal of the British Diabetic Association,
K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
Impaired Awareness of Hypoglycaemia in Insulin-treated Type 2 Diabetes Mellitus.
January 2019, Current diabetes reviews,
K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness.
December 2003, Diabetic medicine : a journal of the British Diabetic Association,
K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes.
January 2010, Diabetes research and clinical practice,
K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
Differential associations of risk factors with severe and non-severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin-treated type 1 diabetes and type 2 diabetes.
June 2024, Diabetes, obesity & metabolism,
K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
Hypoglycaemia in type 2 diabetes treated with pre-mixed insulin.
February 2022, Diabetic medicine : a journal of the British Diabetic Association,
K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
A real-life comparison of hypoglycaemia symptomatology between insulin-treated type 2 diabetes participants with and without impaired awareness of hypoglycaemia.
November 2023, Diabetic medicine : a journal of the British Diabetic Association,
K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
July 2014, Primary care diabetes,
K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
Insulin analogues and severe hypoglycaemia in type 1 diabetes.
April 2012, Diabetes research and clinical practice,
K Akram, and U Pedersen-Bjergaard, and B Carstensen, and K Borch-Johnsen, and B Thorsteinsson
Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin.
January 2001, Diabetes/metabolism research and reviews,
Copied contents to your clipboard!